235 related articles for article (PubMed ID: 34268073)
1. The association between molecular type and prognosis of patients with stage IV breast cancer: an observational study based on SEER database.
Hou L; Qiu M; Chen M; Li F; Li J; Deng S; Yang Y; Du Z; Yang H
Gland Surg; 2021 Jun; 10(6):1889-1898. PubMed ID: 34268073
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
3. Impact of Breast Cancer Subtypes on Prognosis of Women with Operable Invasive Breast Cancer: A Population-based Study Using SEER Database.
Hwang KT; Kim J; Jung J; Chang JH; Chai YJ; Oh SW; Oh S; Kim YA; Park SB; Hwang KR
Clin Cancer Res; 2019 Mar; 25(6):1970-1979. PubMed ID: 30559169
[TBL] [Abstract][Full Text] [Related]
4. Brain metastasis in de novo stage IV breast cancer.
He Y; Shao Y; Chen Q; Liu C; Zhu F; Liu H
Breast; 2023 Oct; 71():54-59. PubMed ID: 37499376
[TBL] [Abstract][Full Text] [Related]
5. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
[TBL] [Abstract][Full Text] [Related]
6. Tumor subtypes and survival in male breast cancer.
Leone J; Freedman RA; Lin NU; Tolaney SM; Vallejo CT; Leone BA; Winer EP; Leone JP
Breast Cancer Res Treat; 2021 Aug; 188(3):695-702. PubMed ID: 33770314
[TBL] [Abstract][Full Text] [Related]
7. Risk and prognostic factors of breast cancer with liver metastases.
Ji L; Cheng L; Zhu X; Gao Y; Fan L; Wang Z
BMC Cancer; 2021 Mar; 21(1):238. PubMed ID: 33676449
[TBL] [Abstract][Full Text] [Related]
8. Association of molecular subtypes and treatment with survival in invasive micropapillary breast cancer: an analysis of the Surveillance, Epidemiology, and End Results database.
Tang Z; Li L; Huang X; Zhao Y; Huang L
Breast Cancer; 2024 Mar; 31(2):205-216. PubMed ID: 38043116
[TBL] [Abstract][Full Text] [Related]
9. Metastatic Pattern Discriminates Survival Benefit of Type of Surgery in Patients With
Li K; Zhou C; Yu Y; Niu L; Zhang W; Wang B; He J; Ge G
Front Surg; 2021; 8():696628. PubMed ID: 34805256
[No Abstract] [Full Text] [Related]
10. Nomogram Predicts the Role of Primary Tumor Surgery on
Cui H; Dai L; Bao Y; Hu L; Zhou Z; Wang M; Lin S; Wu H; Ma X; Kang H
Front Oncol; 2022; 12():819531. PubMed ID: 35600374
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Occult Breast Cancer Patients.
Qu J; Li C; Liu M; Wang Y; Feng Z; Li J; Wang W; Wu F; Zhang S; Zhao X
J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176539
[TBL] [Abstract][Full Text] [Related]
12. Impact of Postoperative Radiotherapy on Survival of Patients With
Zhang J; Luo S; Qiu Z; Lin Y; Song C
Front Oncol; 2021; 11():625628. PubMed ID: 33816261
[No Abstract] [Full Text] [Related]
13. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.
Press DJ; Miller ME; Liederbach E; Yao K; Huo D
Clin Exp Metastasis; 2017 Dec; 34(8):457-465. PubMed ID: 29288366
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program.
Li J; Xia Y; Wu Q; Zhu S; Chen C; Yang W; Wei W; Sun S
Oncotarget; 2017 Jul; 8(30):49370-49379. PubMed ID: 28472761
[TBL] [Abstract][Full Text] [Related]
15. Postmastectomy Radiotherapy Improves Survival Benefits in De Novo Stage IV Breast Cancer: A Propensity-Score Matched Analysis.
Wang X; Liang N; Tian T; Zhang J; Hu P
Technol Cancer Res Treat; 2022; 21():15330338221089937. PubMed ID: 35491730
[No Abstract] [Full Text] [Related]
16. The disparities in prognostic prediction and annualized hazard function in different molecular subtypes between young Chinese and White American women with breast cancer.
Zeng Y; Wang J; Zhong X; Xiang Z; Yang T; Yu S; Dai Z; Xu N; Liu L
Front Oncol; 2023; 13():1199492. PubMed ID: 37492473
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of clinicopathologic characteristics and molecular subtypes of invasive papillary carcinoma of the breast and invasive ductal carcinoma: results from SEER database.
Chen S; Wang J; Yang L; Ji M; Chen S
J BUON; 2021; 26(5):1991-2002. PubMed ID: 34761609
[TBL] [Abstract][Full Text] [Related]
18. Impact of Marital Status on Prognosis of Patients With Invasive Breast Cancer: A Population-Based Study Using SEER Database.
Jiao D; Ma Y; Zhu J; Dai H; Yang Y; Zhao Y; Guo X; Liu Z
Front Oncol; 2022; 12():913929. PubMed ID: 35941872
[TBL] [Abstract][Full Text] [Related]
19. Impact of breast surgery on survival of patients with stage IV breast cancer: a SEER population-based propensity score matching analysis.
Lin Y; Huang K; Zeng Q; Zhang J; Song C
PeerJ; 2020; 8():e8694. PubMed ID: 32219021
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
Gu Y; Wu G; Zou X; Huang P; Yi L
Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
